Li Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li Yang has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Xiang Ma
Department of General Surgery The Second Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China
9 shared publicationsYounan Wang
Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
7 shared publicationsZekuan Xu
Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
7 shared publicationsDakui Luo
Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
6 shared publicationsRan Tang
Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University
6 shared publicationsChao Yang
Liver Transplantation Center of the First Affiliated Hospital and Key Laboratory on Living Donor Liver Transplantation, Ministry of Health, Nanjing Medical University, Nanjing, Jiangsu, China
5 shared publications
Latest Publications
- 20 November 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (2) , 1911-1922
microRNA‐501‐5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1
In spite of the achievement in treatment, the gastric cancer (GC) mortality still remains high. MicroRNAs (miRNAs) are a group of small noncoding RNAs that play a crucial part in tumor progression. In this study, we explored the expression and function of microRNA‐501‐5p (miR‐501‐5p) in GC cell lines. Quantitative real‐time polymerase chain reaction assay results suggested that miR‐501‐5p was significantly upregulated in GC tissues and cell lines. And, the Cell Counting Kit‐8 colony formation and cell migration assay results showed that the downregulation of miR‐501‐5p decreased GC cell proliferation and migration. Besides that, we found that GC cell cycle was arrested in G2 phase and cell apoptosis rate was increased by silencing the expression of miR‐501‐5p in GC cell lines using the flow cytometry. We also found that miR‐501‐5p could directly target lysophosphatidic acid receptor 1 (LPAR1) and negatively regulate LPAR1 expression in GC cell lines by performing dual‐luciferase reporter gene assay and Western blot analysis. And, LPAR1 was significantly downregulated in GC tissues and inversely correlated with miR‐501‐5p expression. Furthermore, LPAR1 downregulation promoted cell proliferation and migration, which were attenuated by cotransfection of miR‐501‐5p inhibitor in GC cells. In conclusion, miR‐501‐5p can promote GC cell proliferation and migration by targeting and downregulating LPAR1. miR‐501‐5p/LPAR1 may become a potential therapeutic target for GC treatment.
- 20 November 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (2) , 1911-1922
microRNA‐501‐5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1
In spite of the achievement in treatment, the gastric cancer (GC) mortality still remains high. MicroRNAs (miRNAs) are a group of small noncoding RNAs that play a crucial part in tumor progression. In this study, we explored the expression and function of microRNA‐501‐5p (miR‐501‐5p) in GC cell lines. Quantitative real‐time polymerase chain reaction assay results suggested that miR‐501‐5p was significantly upregulated in GC tissues and cell lines. And, the Cell Counting Kit‐8 colony formation and cell migration assay results showed that the downregulation of miR‐501‐5p decreased GC cell proliferation and migration. Besides that, we found that GC cell cycle was arrested in G2 phase and cell apoptosis rate was increased by silencing the expression of miR‐501‐5p in GC cell lines using the flow cytometry. We also found that miR‐501‐5p could directly target lysophosphatidic acid receptor 1 (LPAR1) and negatively regulate LPAR1 expression in GC cell lines by performing dual‐luciferase reporter gene assay and Western blot analysis. And, LPAR1 was significantly downregulated in GC tissues and inversely correlated with miR‐501‐5p expression. Furthermore, LPAR1 downregulation promoted cell proliferation and migration, which were attenuated by cotransfection of miR‐501‐5p inhibitor in GC cells. In conclusion, miR‐501‐5p can promote GC cell proliferation and migration by targeting and downregulating LPAR1. miR‐501‐5p/LPAR1 may become a potential therapeutic target for GC treatment.
- Open Access
- 21 June 2018
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 47 (4) , 1465-1481
MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2
Background/Aims: Gastric cancer (GC) is one of the most prevalent digestive malignancies. MicroRNAs (miRNAs) are involved in multiple cellular processes, including oncogenesis, and miR-592 itself participates in many malignancies; however, its role in GC remains unknown. In this study, we investigated the expression and molecular mechanisms of miR-592 in GC. Methods: Quantitative real-time PCR and immunohistochemistry were performed to determine the expression of miR-592 and its putative targets in human tissues and cell lines. Proliferation, migration, and invasion were evaluated by Cell Counting Kit-8, population doubling time, colony formation, Transwell, and wound-healing assays in transfected GC cells in vitro. A dual-luciferase reporter assay was used to determine whether miR-592 could directly bind its target. A tumorigenesis assay was used to study whether miR-592 affected GC growth in vivo. Proteins involved in signaling pathways and the epithelial–mesenchymal transition (EMT) were detected with western blot. Results: The ectopic expression of miR-592 promoted GC proliferation, migration, and invasion in vitro and facilitated tumorigenesis in vivo. Spry2 was a direct target of miR-592 and Spry2 overexpression partially counteracted the effects of miR-592. miR-592 induced the EMT and promoted its progression in GC via the PI3K/AKT and MAPK/ERK signaling pathways by inhibiting Spry2. Conclusions: Overexpression of miR-592 promotes GC proliferation, migration, and invasion and induces the EMT via the PI3K/AKT and MAPK/ERK signaling pathways by inhibiting Spry2, suggesting a potential therapeutic target for GC.
- 21 June 2018
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 47 (4) , 1465-1481
Open AccessMiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2
Background/Aims: Gastric cancer (GC) is one of the most prevalent digestive malignancies. MicroRNAs (miRNAs) are involved in multiple cellular processes, including oncogenesis, and miR-592 itself participates in many malignancies; however, its role in GC remains unknown. In this study, we investigated the expression and molecular mechanisms of miR-592 in GC. Methods: Quantitative real-time PCR and immunohistochemistry were performed to determine the expression of miR-592 and its putative targets in human tissues and cell lines. Proliferation, migration, and invasion were evaluated by Cell Counting Kit-8, population doubling time, colony formation, Transwell, and wound-healing assays in transfected GC cells in vitro. A dual-luciferase reporter assay was used to determine whether miR-592 could directly bind its target. A tumorigenesis assay was used to study whether miR-592 affected GC growth in vivo. Proteins involved in signaling pathways and the epithelial–mesenchymal transition (EMT) were detected with western blot. Results: The ectopic expression of miR-592 promoted GC proliferation, migration, and invasion in vitro and facilitated tumorigenesis in vivo. Spry2 was a direct target of miR-592 and Spry2 overexpression partially counteracted the effects of miR-592. miR-592 induced the EMT and promoted its progression in GC via the PI3K/AKT and MAPK/ERK signaling pathways by inhibiting Spry2. Conclusions: Overexpression of miR-592 promotes GC proliferation, migration, and invasion and induces the EMT via the PI3K/AKT and MAPK/ERK signaling pathways by inhibiting Spry2, suggesting a potential therapeutic target for GC.
- 5 January 2018
- Published by Spandidos Publications in Oncology Reports
- Vol. 39 (3) , 1207-1214
MicroRNA-let-7a regulates cell autophagy by targeting Rictor in gastric cancer cell lines MGC-803 and SGC-7901
MiR-let-7a is the most widely studied miRNA, whose functions have been well-established by scientists in both carcinogenesis and progression of human cancer, including gastric cancer (GC). However, to date there is a lack of information concerning the relationship between miR-let-7a and cellular autophagy. Using western blotting and immunofluorescence, we determined that upregulation of miR-let-7a led to increased cellular autophagic level, whereas miR-let-7a suppression decreased autophagy activity in GC cells. To further elucidate the mechanisms underlying this, we screened potential targets of miR-let-7a using bioinformatics analyses, validated by a series of assays. Our results indicated that Rptor independent companion of mTOR complex 2 (Rictor) was a direct target of miR-let-7a. In addition, rescue experiments in vitro showed that miR-let-7a promoted cellular autophagic level by inhibiting Rictor expression in GC cells. Furthermore, as an upstream executor of Akt-mTOR signaling pathway, we found that Rictor elaborated its effect on autophagy by phosphorylating Akt and mTOR, and this regulatory process could also be mediated by miR-let-7a. Taken together, our results present a novel role for miR-let-7a in GC which modulates autophagy by targeting Rictor, following the regulation of Akt-mTOR signal pathway.
- 5 January 2018
- Published by Spandidos Publications in Oncology Reports
- Vol. 39 (3) , 1207-1214
MicroRNA-let-7a regulates cell autophagy by targeting Rictor in gastric cancer cell lines MGC-803 and SGC-7901
MiR-let-7a is the most widely studied miRNA, whose functions have been well-established by scientists in both carcinogenesis and progression of human cancer, including gastric cancer (GC). However, to date there is a lack of information concerning the relationship between miR-let-7a and cellular autophagy. Using western blotting and immunofluorescence, we determined that upregulation of miR-let-7a led to increased cellular autophagic level, whereas miR-let-7a suppression decreased autophagy activity in GC cells. To further elucidate the mechanisms underlying this, we screened potential targets of miR-let-7a using bioinformatics analyses, validated by a series of assays. Our results indicated that Rptor independent companion of mTOR complex 2 (Rictor) was a direct target of miR-let-7a. In addition, rescue experiments in vitro showed that miR-let-7a promoted cellular autophagic level by inhibiting Rictor expression in GC cells. Furthermore, as an upstream executor of Akt-mTOR signaling pathway, we found that Rictor elaborated its effect on autophagy by phosphorylating Akt and mTOR, and this regulatory process could also be mediated by miR-let-7a. Taken together, our results present a novel role for miR-let-7a in GC which modulates autophagy by targeting Rictor, following the regulation of Akt-mTOR signal pathway.
- Open Access
- 8 October 2017
- Published by Wiley in Cancer Science
- Vol. 108 (12) , 2503-2510
Phosphorylation of ETS‐1 is a critical event in DNA polymerase iota‐induced invasion and metastasis of esophageal squamous cell carcinoma
An aberrantly elevated expression of DNA polymerase ι (Pol ι) is significantly associated with poor prognosis of patients with esophageal squamous cell carcinoma (ESCC), yet the mechanisms behind this phenomenon remain obscure. Based on the RNA‐Seq transcriptome and real‐time PCR analysis, we identified ETS‐1 as a candidate gene involved in Pol ι‐mediated progression of ESCC. Wound‐healing and transwell assay indicated that downregulation of ETS‐1 attenuates Pol ι‐mediated invasiveness of ESCC. Signaling pathway analysis showed that Pol ι enhances ETS‐1 phosphorylation at threonine‐38 through the Erk signaling pathway in ESCC cells. Kaplan–Meier analysis, based on 93 clinical tissue samples, revealed that ETS‐1 phosphorylation at threonine‐38 is associated with poor prognosis of ESCC patients. The present study thus demonstrates that phosphorylation of ETS‐1 is a critical event in the Pol ι‐induced invasion and metastasis of ESCC.
- 8 October 2017
- Published by Wiley in Cancer Science
- Vol. 108 (12) , 2503-2510
Open AccessPhosphorylation of ETS‐1 is a critical event in DNA polymerase iota‐induced invasion and metastasis of esophageal squamous cell carcinoma
An aberrantly elevated expression of DNA polymerase ι (Pol ι) is significantly associated with poor prognosis of patients with esophageal squamous cell carcinoma (ESCC), yet the mechanisms behind this phenomenon remain obscure. Based on the RNA‐Seq transcriptome and real‐time PCR analysis, we identified ETS‐1 as a candidate gene involved in Pol ι‐mediated progression of ESCC. Wound‐healing and transwell assay indicated that downregulation of ETS‐1 attenuates Pol ι‐mediated invasiveness of ESCC. Signaling pathway analysis showed that Pol ι enhances ETS‐1 phosphorylation at threonine‐38 through the Erk signaling pathway in ESCC cells. Kaplan–Meier analysis, based on 93 clinical tissue samples, revealed that ETS‐1 phosphorylation at threonine‐38 is associated with poor prognosis of ESCC patients. The present study thus demonstrates that phosphorylation of ETS‐1 is a critical event in the Pol ι‐induced invasion and metastasis of ESCC.
- Open Access
- 1 January 2017
- Published by Wiley in Disease Markers
- Vol. 2017, 1-8
Polymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population
Long noncoding RNA (lncRNA) phosphatase and tensin homolog pseudogene 1 (PTENP1) is significantly downregulated in gastric cancer (GC), playing critical roles in GC progression. However, the association between PTENP1 genetic variants and GC risk has not yet been reported. Using TaqMan technology, three lncRNA PTENP1 tag single nucleotide polymorphisms (tagSNPs) (rs7853346 C>G, rs865005 C>T, and rs10971638 G>A) were genotyped in 768 GC patients and 768 cancer-free controls in a Chinese population. We found that subjects with rs7853346 G allele had a remarkably decreased risk of GC, compared with those carrying C allele ( in an additive model, after Bonferroni’s correction). The further stratified analyses showed that the link between variant genotypes of rs7853346 and decreased GC risk was more obvious in older subjects (≥60 years), nonsmokers, nondrinkers, and subjects without family history of GC. We also found that relative PTENP1 mRNA expression levels were higher in rs7853346 CG/GG genotype carriers than those with common genotype in both GC and normal tissues (). Besides, bioinformatics analyses revealed that rs7853346 may change the local folding structure and alter the target microRNAs (miRNAs) of PTENP1. In conclusion, our results suggested that lncRNA PTENP1 polymorphism rs7853346 may predict GC susceptibility.- 1 January 2017
- Published by Wiley in Disease Markers
- Vol. 2017, 1-8
Open AccessPolymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population
Long noncoding RNA (lncRNA) phosphatase and tensin homolog pseudogene 1 (PTENP1) is significantly downregulated in gastric cancer (GC), playing critical roles in GC progression. However, the association between PTENP1 genetic variants and GC risk has not yet been reported. Using TaqMan technology, three lncRNA PTENP1 tag single nucleotide polymorphisms (tagSNPs) (rs7853346 C>G, rs865005 C>T, and rs10971638 G>A) were genotyped in 768 GC patients and 768 cancer-free controls in a Chinese population. We found that subjects with rs7853346 G allele had a remarkably decreased risk of GC, compared with those carrying C allele ( in an additive model, after Bonferroni’s correction). The further stratified analyses showed that the link between variant genotypes of rs7853346 and decreased GC risk was more obvious in older subjects (≥60 years), nonsmokers, nondrinkers, and subjects without family history of GC. We also found that relative PTENP1 mRNA expression levels were higher in rs7853346 CG/GG genotype carriers than those with common genotype in both GC and normal tissues (). Besides, bioinformatics analyses revealed that rs7853346 may change the local folding structure and alter the target microRNAs (miRNAs) of PTENP1. In conclusion, our results suggested that lncRNA PTENP1 polymorphism rs7853346 may predict GC susceptibility. - Open Access
- 21 December 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (7) , 11507-11516
Identification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese population
Identification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese population Identification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese Population
- 21 December 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (7) , 11507-11516
Open AccessIdentification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese population
Identification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese population Identification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese Population
- Open Access
- 1 September 2016
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 9, 5975-5983
Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study
Purpose: Disheveled-binding antagonist of beta-catenin 1 (DACT1) is involved in tumorigenesis through influencing cell apoptosis and proliferation. We aimed to investigate the effect of three tag single-nucleotide polymorphisms (SNPs) in DACT1 (rs863091 C>T, rs17832998 C>T, and rs167481 C>T) on the occurrence of gastric cancer (GC), their association with specific clinical characteristics, and consideration of the functional relevance of GC-related SNPs. Subjects and methods: In this hospital-based case–control study, the genotypes were acquired using the TaqMan-MGB method consisting of 602 cases and 602 controls. DACT1 messenger RNA level was evaluated in 76 paired tumoral and normal tissues using quantitative reverse transcription–polymerase chain reaction. Logistic regression was used to evaluate the associations among the DACT1 SNPs and GC. Results: We found a significant association between the variant genotypes of rs863091 and decreased risk of GC (TT vs CC: P=0.009, adjusted odds ratio =0.34, 95% confidence interval =0.15–0.77; CT + TT vs CC: P=0.030, adjusted odds ratio =0.74, 95% confidence interval =0.57–0.97). In further stratified analyses, rs863091 variant genotypes were associated with a reduced risk of GC in younger individuals (T polymorphism may be associated with a decreased risk of GC in the Chinese Han population and influence DACT1 expression.
- 1 September 2016
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 9, 5975-5983
Open AccessAssociation analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study
Purpose: Disheveled-binding antagonist of beta-catenin 1 (DACT1) is involved in tumorigenesis through influencing cell apoptosis and proliferation. We aimed to investigate the effect of three tag single-nucleotide polymorphisms (SNPs) in DACT1 (rs863091 C>T, rs17832998 C>T, and rs167481 C>T) on the occurrence of gastric cancer (GC), their association with specific clinical characteristics, and consideration of the functional relevance of GC-related SNPs. Subjects and methods: In this hospital-based case–control study, the genotypes were acquired using the TaqMan-MGB method consisting of 602 cases and 602 controls. DACT1 messenger RNA level was evaluated in 76 paired tumoral and normal tissues using quantitative reverse transcription–polymerase chain reaction. Logistic regression was used to evaluate the associations among the DACT1 SNPs and GC. Results: We found a significant association between the variant genotypes of rs863091 and decreased risk of GC (TT vs CC: P=0.009, adjusted odds ratio =0.34, 95% confidence interval =0.15–0.77; CT + TT vs CC: P=0.030, adjusted odds ratio =0.74, 95% confidence interval =0.57–0.97). In further stratified analyses, rs863091 variant genotypes were associated with a reduced risk of GC in younger individuals (T polymorphism may be associated with a decreased risk of GC in the Chinese Han population and influence DACT1 expression.
- 25 May 2016
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 2 (5) , 101
Simultaneous laparoscopic distal gastrectomy (uncut Roux-en-Y anastomosis), right hemi-colectomy and radical rectectomy (Dixon) in a synchronous triple primary stomach, colon and rectal cancers patient
Background: Gastric and colorectal cancers are both one of the most common tumors worldwide, while the morbidity of multiple synchronous primary tumors are really rare, and triple synchronous primary cancers are considered has a lower incidence. In this report, we demonstrate a rare case of synchronous triple primary cancers involving gastric, colon and rectal, and the laparoscopic operation procedure of the patient. Methods: A 49-year-old male diagnosed with synchronous triple primary gastric, colon and rectal cancer, underwent simultaneous laparoscopic distal gastrectomy (uncut Roux-en-Y anastomosis, D2), right hemi-colectomy and radical rectectomy (Dixon). Results: The operation lasts 305 min with about 300 mL blood lost. The patient discharged from hospital on the 12th day without any complication. Conclusions: Laparoscopic surgery is a safe and feasible way in synchronous gastrointestinal triple primary cancers. Nevertheless, because of the rare incidence, many details and specific condition should be considered during the peri-operative period of this multiple synchronous cancers patient.
- 25 May 2016
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 2 (5) , 101
Simultaneous laparoscopic distal gastrectomy (uncut Roux-en-Y anastomosis), right hemi-colectomy and radical rectectomy (Dixon) in a synchronous triple primary stomach, colon and rectal cancers patient
Background: Gastric and colorectal cancers are both one of the most common tumors worldwide, while the morbidity of multiple synchronous primary tumors are really rare, and triple synchronous primary cancers are considered has a lower incidence. In this report, we demonstrate a rare case of synchronous triple primary cancers involving gastric, colon and rectal, and the laparoscopic operation procedure of the patient. Methods: A 49-year-old male diagnosed with synchronous triple primary gastric, colon and rectal cancer, underwent simultaneous laparoscopic distal gastrectomy (uncut Roux-en-Y anastomosis, D2), right hemi-colectomy and radical rectectomy (Dixon). Results: The operation lasts 305 min with about 300 mL blood lost. The patient discharged from hospital on the 12th day without any complication. Conclusions: Laparoscopic surgery is a safe and feasible way in synchronous gastrointestinal triple primary cancers. Nevertheless, because of the rare incidence, many details and specific condition should be considered during the peri-operative period of this multiple synchronous cancers patient.
- Open Access
- 5 January 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (5) , 5972-5984
MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer
MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer
- 5 January 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (5) , 5972-5984
Open AccessMiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer
MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer